Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US EP News Bureau Aug 31, 2020 Mylan is offering Semglee at a wholesale acquisition cost (WAC) of $147.98 per package of five 3ml pens and $98.65 per 10ml vial
Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection EP News Bureau Jun 12, 2020 FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans…
